T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.52B |
| 2 |
Boeing
BA
|
+$1.89B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.43B |
| 4 |
Amphenol
APH
|
+$1.1B |
| 5 |
CME Group
CME
|
+$911M |
Top Sells
| 1 |
Apple
AAPL
|
+$3.87B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.1B |
| 3 |
UnitedHealth
UNH
|
+$1.83B |
| 4 |
Uber
UBER
|
+$1.56B |
| 5 |
Adobe
ADBE
|
+$1.29B |
Sector Composition
| 1 | Technology | 33.26% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.7% |
| 4 | Financials | 11.14% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Shoals Technologies Group
SHLS
$1.15B
| $623K | ﹤0.01% |
112,523
-29,400
| -21% | -$163K |
|
2177
Ingles Markets
IMKTA
$1.32B
| $620K | ﹤0.01% |
9,611
+936
| +11% | +$60.4K |
|
2178
Genesco
GCO
$355M
| $616K | ﹤0.01% |
14,392
+650
| +5% | +$27.8K |
|
2179
Burke & Herbert Financial Services Corp
BHRB
$935M
| $613K | ﹤0.01% |
9,829
+5,319
| +118% | +$332K |
|
2180
Scansource
SCSC
$985M
| $612K | ﹤0.01% |
12,897
+1,358
| +12% | +$64.4K |
|
2181
Compass Diversified
CODI
$533M
| $611K | ﹤0.01% |
26,445
+4,632
| +21% | +$107K |
|
2182
Theravance Biopharma
TBPH
$703M
| $610K | ﹤0.01% |
64,795
+9,315
| +17% | +$87.7K |
|
2183
BrightView Holdings
BV
$1.33B
| $608K | ﹤0.01% |
37,990
+3,779
| +11% | +$60.5K |
|
2184
Appian
APPN
$2.29B
| $605K | ﹤0.01% |
18,329
-76,203
| -81% | -$2.52M |
|
2185
Castle Biosciences
CSTL
$644M
| $605K | ﹤0.01% |
22,697
+1,837
| +9% | +$49K |
|
2186
Myriad Genetics
MYGN
$710M
| $605K | ﹤0.01% |
44,089
-10,253
| -19% | -$141K |
|
2187
Jamf
JAMF
$1.38B
| $604K | ﹤0.01% |
42,935
+5,109
| +14% | +$71.9K |
|
2188
Greenlight Captial
GLRE
$429M
| $600K | ﹤0.01% |
42,827
+7,321
| +21% | +$103K |
|
2189
NVE Corp
NVEC
$326M
| $600K | ﹤0.01% |
7,363
+939
| +15% | +$76.5K |
|
2190
Nuvation Bio
NUVB
$1.09B
| $599K | ﹤0.01% |
225,025
+9,758
| +5% | +$26K |
|
2191
Shore Bancshares
SHBI
$568M
| $599K | ﹤0.01% |
37,746
-12,213
| -24% | -$194K |
|
2192
HealthStream
HSTM
$856M
| $598K | ﹤0.01% |
18,785
+1,550
| +9% | +$49.3K |
|
2193
Koppers
KOP
$557M
| $597K | ﹤0.01% |
18,422
+1,254
| +7% | +$40.6K |
|
2194
Bumble
BMBL
$706M
| $596K | ﹤0.01% |
73,204
-12,008
| -14% | -$97.8K |
|
2195
Xperi
XPER
$281M
| $596K | ﹤0.01% |
58,001
-8,608
| -13% | -$88.5K |
|
2196
Ambac
AMBC
$411M
| $593K | ﹤0.01% |
46,835
+7,042
| +18% | +$89.2K |
|
2197
Microvision
MVIS
$340M
| $592K | ﹤0.01% |
451,837
+18,130
| +4% | +$23.8K |
|
2198
Kforce
KFRC
$570M
| $591K | ﹤0.01% |
10,421
+1,072
| +11% | +$60.8K |
|
2199
Arcutis Biotherapeutics
ARQT
$2.06B
| $590K | ﹤0.01% |
42,349
-17,799
| -30% | -$248K |
|
2200
Sinclair Inc
SBGI
$965M
| $590K | ﹤0.01% |
36,500
+2,035
| +6% | +$32.9K |
|